Quarterly Result24 May 2025, 08:52 pm
HealthCare Global Enterprises Ltd Reports 13% Revenue Growth in Q4FY25, 16% for FY25
AI Summary
HealthCare Global Enterprises Ltd (HCG), a leading provider of cancer care in India, announced its Financial Results for the 4th Quarter and Full Year ended 31st March 2025. The company reported a 13% increase in revenue, 14% in Adjusted EBITDA, and a 66% decrease in Profit After Tax for Q4FY25 compared to the same period last year. For FY25, the revenue increased by 16%, Adjusted EBITDA by 17%, and Profit After Tax by 8% Y-o-Y. The revenue breakup shows a growth in both established and emerging centers. The company also reported an increase in Operational KPIs and made strategic investments in next-generation capabilities.
Key Highlights
- 13% increase in revenue for Q4FY25, 16% for FY25
- 14% growth in Adjusted EBITDA for Q4FY25, 17% for FY25
- 66% decrease in Profit After Tax for Q4FY25, 8% increase for FY25
- Investment in next-generation capabilities, including the acquisition of Orbitrap Astral Mass Spectrometer from Thermo Fisher Scientific
- Strong growth in operational KPIs